Amid a backdrop of global economic fluctuations and recent interest rate cuts by the European Central Bank, the Hong Kong market has shown resilience, with technology stocks gaining particular attention. In this environment, identifying high-growth tech stocks involves looking for companies that demonstrate strong innovation potential and robust financial health.

Top 10 High Growth Tech Companies In Hong Kong

Click here to see the full list of 45 stocks from our SEHK High Growth Tech and AI Stocks screener.

Let's review some notable picks from our screened stocks.

Tencent Holdings (SEHK:700)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Tencent Holdings Limited, an investment holding company, provides a diverse range of services including value-added services (VAS), online advertising, fintech, and business services in China and globally, with a market cap of approximately HK$3.50 trillion.

Operations: Tencent generates revenue primarily through its Value-Added Services (VAS), which contribute CN¥302.28 billion, followed by Fintech and Business Services at CN¥209.17 billion, and Online Advertising at CN¥111.89 billion.

Tencent Holdings' recent performance highlights its robust growth trajectory, with Q2 2024 revenue reaching ¥161.12 billion, up from ¥149.21 billion year-on-year. Net income surged to ¥47.63 billion from ¥26.17 billion, reflecting strong operational efficiency and strategic investments in AI and cloud services. The company repurchased shares this year, enhancing shareholder value while maintaining an R&D expense ratio of approximately 8% of revenue, underscoring its commitment to innovation in gaming and fintech sectors.

• Dive into the specifics of Tencent Holdings here with our thorough health report.

• Review our historical performance report to gain insights into Tencent Holdings''s past performance.

Lenovo Group (SEHK:992)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Lenovo Group Limited, an investment holding company, develops, manufactures, and markets technology products and services with a market cap of HK$117.10 billion.

Operations: Lenovo Group generates revenue primarily from three segments: Intelligent Devices Group (IDG) at $45.76 billion, Solutions and Services Group (SSG) at $7.64 billion, and Infrastructure Solutions Group (ISG) at $10.17 billion. The company's diverse product portfolio includes technology products and services aimed at various market needs.

Lenovo's recent advancements in hybrid cloud and AI services underscore its commitment to innovation, with R&D expenses reaching $1.2 billion, or 7.9% of revenue. The company's earnings are projected to grow at an annual rate of 18.6%, outpacing the Hong Kong market average of 11.7%. Lenovo's strategic partnerships and new product offerings, such as the AD1 domain controller for autonomous driving, highlight its focus on high-performance computing and AI-driven solutions, positioning it well for future growth in these sectors.

• Click to explore a detailed breakdown of our findings in Lenovo Group's health report.

• Understand Lenovo Group's track record by examining our Past report.

Akeso (SEHK:9926)

Simply Wall St Growth Rating: ★★★★★★

Overview: Akeso, Inc. is a biopharmaceutical company that researches, develops, manufactures, and commercializes antibody drugs with a market cap of HK$62.51 billion.

Operations: Akeso focuses on the research, development, production, and sale of biopharmaceutical products, generating CN¥1.87 billion in revenue. The company specializes in antibody drugs within the biopharmaceutical sector.

Akeso's recent advancements in oncology treatments, particularly with ivonescimab, highlight its innovative edge in the biotech sector. At the 2024 ESMO Conference, phase 2 results showcased a promising 72.4% objective response rate and a disease control rate of 100% for TNBC patients. Despite reporting a net loss of ¥238.59 million for H1 2024, significant R&D investment remains evident with expenses accounting for approximately ¥1 billion annually. The company's focus on high-efficacy cancer therapies positions it well for future growth amidst increasing demand for advanced medical solutions.

• Get an in-depth perspective on Akeso's performance by reading our health report here.

• Learn about Akeso's historical performance.

Where To Now?

• Dive into all 45 of the SEHK High Growth Tech and AI Stocks we have identified here.
• Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
• Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.

Seeking Other Investments?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com